Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (7)

2024

  1. Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish Patients

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 8, pp. 761-765

  2. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245

2023

  1. Corrigendum: The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases(Front. Immunol., (2023), 14, (1191782), 10.3389/fimmu.2023.1191782)

    Frontiers in Immunology

  2. Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 12, pp. 2517-2525

  3. Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

    Actas Dermo-Sifiliograficas

  4. Selection of Quality Indicators for the Certification of Psoriasis Units: The CUDERMA Project Delphi Consensus Study

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 10, pp. 865-883

  5. The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases

    Frontiers in Immunology, Vol. 14